Spleen Stiffness Measurement for Fatty Liver Disease

This trial aims to improve early detection of serious liver disease in individuals with fatty liver disease. Researchers will measure spleen stiffness, which may indicate the severity of liver disease. The study employs vibration-controlled transient elastography, a tool for assessing organ stiffness, to examine both the liver and spleen. Individuals diagnosed with fatty liver disease through prior tests or medical records are suitable candidates for this trial. As an unphased trial, it provides a unique opportunity to contribute to groundbreaking research that could enhance early detection methods for liver disease.

The trial information does not specify whether you need to stop taking your current medications.

Research has shown that vibration-controlled transient elastography (VCTE) is generally safe and easy to use. Medical settings often employ this method to assess liver stiffness without invasive procedures.

Studies have found that VCTE effectively predicts liver problems in individuals with fatty liver disease. No serious side effects have been reported from using this method. It operates by sending gentle vibrations through a device to the skin over the liver and spleen to measure stiffness.

Researchers are excited about using vibration-controlled transient elastography for fatty liver disease because it offers a non-invasive way to measure liver and spleen stiffness, which can be crucial for early detection and monitoring of the disease. Unlike traditional liver biopsies, which are invasive and can be uncomfortable, this technique uses painless vibrations to assess organ stiffness, making it more patient-friendly. This method could lead to quicker, more frequent assessments, potentially improving patient outcomes by allowing for timely interventions.

Research has shown that vibration-controlled transient elastography (VCTE) benefits people with fatty liver disease. In this trial, participants with metabolic-dysfunction associated steatotic liver disease will undergo liver and spleen stiffness measurements using VCTE. Studies have found that VCTE scores accurately predict liver-related issues, helping to identify potential liver problems early. This non-invasive test does not involve surgery and effectively detects liver stiffness and scarring. Early detection of liver problems is crucial, as it can prevent serious health issues. Overall, VCTE offers a promising method to assess liver health in individuals with liver disease related to metabolic problems.¹²³⁴⁶